Key facts
- Scotmas’s last known valuation is $9.9M (Dec 2024).
- It has raised $4.7M; the latest was PE Growth/Expansion ($2.8M) in Dec 2024.
- Notable investors include Innovate UK, Scottish Enterprise, Maven Capital Partners UK.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Scotmas
- ·The full record, as it builds
Funding rounds
No funding rounds for Scotmas are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Scotmas
Manufacturer of water treatment dosing systems designed for diverse sectors such as agriculture, water treatment, food and drink processing, healthcare, farming, and others. The company offers chlorine dioxide (ClO₂) systems and tablets to control bacteria and other pathogens in water and food contact surfaces, providing clients with purified water protected against contaminants.
- Sector
- Business Products and Services (B2B)
- HQ
- Kelso, United Kingdom
- Founded
- 1998
- Employees
- 52
- Website
- scotmas.com/
- Ownership
- Privately Held (backing)
Scotmas doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Scotmas shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Scotmas in its N-PORT filings yet. We sweep new filings monthly.